Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04371900
Other study ID # HUM00132909B
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 26, 2018
Est. completion date December 31, 2049

Study information

Verified date May 2024
Source University of Michigan
Contact Vanessa Lang, PhD
Phone 1-844-864-8258
Email m-carestudy@umich.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project builds on the Michigan Contraceptive Access Research and Evaluation Study (M-CARES) to evaluate the long-term effects of mothers' access to free contraceptives and reductions in unintended pregnancies on their children's well-being.


Description:

M-CARES uses a randomized control trial design to assess the effects of providing free contraception to mothers on their children born before the intervention. The population subject to intervention is fecund women age 18-35 years at risk of pregnancy and who are clients at Planned Parenthood clinics of Michigan (PPMI), who meet income eligibility criteria, and who would otherwise pay out-of-pocket for services on the day of recruitment (i.e., lacking insurance coverage for received service). The experimental (treatment) condition is a mother's receipt of a voucher providing access to no-cost contraception (up to the price of a name-brand intrauterine device) for 100 days. The control group of mothers receives no voucher. All enrolled women complete a two-part baseline survey and consent to be re-contacted for two follow-up interviews in outgoing years. They also complete a two-part baseline survey and consent to be re-contacted for two follow up interviews in outgoing years. In addition, mothers consent to linkages to their own and their children's administrative data from records held by state and federal health, education, criminal justice, and tax records. Consent covers children already born to women at the time of intervention and children born after intervention. Survey and administrative data provide outcome measures to assess children's well-being and development up to age 18. The study will compare children of mothers who receive the intervention to those who did not.


Recruitment information / eligibility

Status Recruiting
Enrollment 4700
Est. completion date December 31, 2049
Est. primary completion date December 31, 2049
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 0 Years to 17 Years
Eligibility Inclusion Criteria: The proposed project will analyze the outcomes of children ages 0 to 17 years old whose mothers enrolled in the Michigan Contraceptive Access, Research and Evaluation Study (M-CARES). M-CARES participation requires that mothers are: - 18-35 years old - physically capable (biologically female and fecund) and at risk of having a pregnancy, - not pregnant at the time of enrollment - not wishing to become pregnant in the 12 months after enrollment, - are seeking care at Planned Parenthood of Michigan, and - face out-of-pocket costs for contraceptives at Planned Parenthood of Michigan.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mother receives voucher valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023)
M-CARES randomized vouchers for contraception valued up to 100% of inserting a name-brand IUD (e.g., Skyla, Paraguard, Mirena) for women with out of pocket costs at Planned Parenthood. This intervention occurred from March 4, 2019, forward.
Mother receives voucher valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019)
M-CARES randomized vouchers for contraception valued up to 50% of inserting a name-brand IUD (e.g., Skyla, Paraguard, Mirena) for women with out of pocket costs at Planned Parenthood. This intervention occurred after November 4, 2019.

Locations

Country Name City State
United States Planned Parenthood - Ann Arbor-West Ann Arbor Michigan
United States Planned Parenthood - Detroit Detroit Michigan
United States Planned Parenthood - Ferndale Ferndale Michigan
United States Planned Parenthood - Grand Rapids Grand Rapids Michigan
United States Planned Parenthood - Kalamazoo Kalamazoo Michigan
United States Planned Parenthood - Lansing Lansing Michigan
United States Planned Parenthood - Livonia Livonia Michigan
United States Planned Parenthood - Traverse City Traverse City Michigan
United States Planned Parenthood - Warren Warren Michigan

Sponsors (3)

Lead Sponsor Collaborator
University of Michigan National Opinion Research Center, Planned Parenthood Federation of America

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of siblings born after study enrollment (1 year) Number of children born to individual's mother as determined in mother's survey responses and Vital Records (count: 0, 1, 2....) Up to 1 year post enrollment
Primary Number of siblings born after study enrollment (3 year) Number of children born to individual's mother as determined in mother's survey responses and Vital Records (count: 0, 1, 2....) Up to 3 year post enrollment
Primary Number of siblings born after study enrollment (5 year) Number of children born to individual's mother as determined in mother's survey responses and Vital Records (count: 0, 1, 2....) Up to 5 year post enrollment
Primary Standardized achievement test score (1 year) Percentile on state standardized achievement test (range: 1-100) Up to 1 year post enrollment
Primary Standardized achievement test score (3 year) Percentile on state standardized achievement test (range: 1-100) Up to 3 year post enrollment
Primary Standardized achievement test score (5 year) Percentile on state standardized achievement test (range: 1-100) Up to 5 year post enrollment
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Terminated NCT02546193 - Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction N/A